The Global HIV/AIDS Epidemic: An Updated Overview

HIV, the virus that causes AIDS (acquired immunodeficiency syndrome), remains one of the world’s most significant public health challenges. Whereas substantial progress has been made in prevention and treatment, millions are still affected and a cure remains elusive. This article provides an updated overview of the global HIV/AIDS epidemic, its impact, and ongoing efforts to combat it.

Global Impact and Statistics

As of 2024, approximately 40.8 million people are living with HIV worldwide. Since the beginning of the epidemic, roughly 91.4 million people have been infected with HIV, and tens of millions have died from AIDS-related causes [HIV.gov]. In 2024 alone, there were approximately 1.3 million fresh HIV infections, equating to about 3,500 new infections per day [KFF].

Despite the ongoing challenges, there has been progress. AIDS-related deaths have declined by 55% since 2010, reaching 630,000 in 2024 [KFF]. This decline is largely attributed to increased access to antiretroviral therapy (ART).

Understanding HIV and AIDS

HIV (Human Immunodeficiency Virus) is transmitted through certain body fluids and weakens the immune system by destroying CD4 cells (T cells) [KFF]. If left untreated, HIV compromises the body’s ability to fight off infections and diseases.

AIDS (Acquired Immunodeficiency Syndrome), or Advanced HIV Disease, develops when the immune system is severely damaged by HIV [KFF]. While historically associated with late diagnosis and treatment, AIDS is now more commonly seen in individuals who have stopped ART.

Affected and Vulnerable Populations

While HIV can affect anyone, certain populations are disproportionately impacted. These include:

• Men who have sex with men
• People who inject drugs
• Sex workers
• Transgender individuals
• People in prisons

Women and girls represent over half (53%) of all people living with HIV globally [KFF]. Gender inequalities and increased biological susceptibility contribute to this disparity.

Children are also vulnerable, with 1.4 million children living with HIV in 2024. Although, new HIV infections among children have declined by 62% since 2010 [KFF].

Prevention and Treatment Strategies

Effective prevention strategies include:

• Behavioral changes
• Condom use
• HIV testing
• Blood supply safety
• Harm reduction programs for injecting drug users
• Male circumcision

Pre-exposure prophylaxis (PrEP) has emerged as a highly effective prevention method for individuals at high risk of HIV infection [KFF]. Recent advancements include long-acting injectable PrEP options.

Antiretroviral therapy (ART) remains the cornerstone of HIV treatment. Combination ART attacks the virus and prevents it from progressing to AIDS. When individuals with HIV achieve viral suppression through ART, they effectively have no risk of transmitting the virus sexually [KFF].

Global Response and Goals

International efforts to combat HIV began in 1987 with the creation of the WHO’s Global Programme on AIDS. Key initiatives include:

• UNAIDS: The coordinating body within the U.N. System.
• The Global Fund to Fight AIDS, Tuberculosis and Malaria: An independent financing institution providing grants to countries.
• PEPFAR (The President’s Emergency Plan for AIDS Relief): The U.S. Government’s global initiative, which has directed over $130 billion toward HIV prevention, care, and treatment since 2003.

Global goals, aligned with the Sustainable Development Goals (SDGs), aim to end AIDS as a public health threat by 2030. Interim targets include achieving 95-95-95 by 2025: 95% of people living with HIV knowing their status, 95% of those diagnosed on treatment, and 95% of those on treatment with suppressed viral loads [KFF].

Challenges and Future Directions

Despite progress, significant challenges remain. These include:

• Unequal access to prevention, treatment, and care
• The lack of a cure
• Stigma and discrimination
• Funding gaps

Continued investment in research, prevention programs, and treatment access is crucial to achieving the goal of ending the HIV/AIDS epidemic. Addressing social determinants of health and reducing inequalities are also essential for sustained progress.